Series B Round

ClarityCare AI is developing an AI-driven platform targeted at healthcare operations, focusing on automating prior authorization processes to enhance efficiency and compliance in healthcare administration. The company aims to transform utilization management with generative AI, utilizing intelligent agents to pre-fill and review prior-authorization requests, thereby streamlining healthcare workflows. This funding will support the launch of their first FDA-authorized AI platform for breast cancer risk prediction, which is expected to significantly improve patient outcomes and reduce administrative burdens on healthcare providers.